Endo Swallows Fort Lee Generic Pill Maker
Pharmaceutical developer and manufacturer Endo International, which is headquartered in Malvern, agreed to swallow up generic drug maker DAVA Pharmaceuticals, and a spoonful of “meaningful upside” helped the medicine go down.
Endo President and CEO Rajiv De Silva “called DAVA a ‘natural fit’ for Endo’s generics business and said DAVA is well-positioned for continued ‘strong and highly predictable financial performance with its existing commercial portfolio and attractive near-term pipeline,’” the Philadelphia Business Journal reported.
The $575 million cash and $25 million performance deal is thought to be financed by an offering of senior notes.
Read more about the acquisition in the Philadelphia Business Journal here.
Connect With Your Community
Subscribe to stay informed!
"*" indicates required fields